Mackenzie Financial Corp Organon & Co. Transaction History

Mackenzie Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.78 - $18.8 $861,415 - $1.18 Million	62,512 New	62,512 $1.18 Million
Q3 2023 Oct 25, 2023	BUY	$16.59 - $23.77 $15,461 - $22,153	932 Added 7.63%	13,148 $228,000
Q2 2023 Aug 03, 2023	BUY	$19.27 - $24.63 $12,448 - $15,910	646 Added 5.58%	12,216 $254,000
Q1 2023 Apr 24, 2023	SELL	$21.42 - $32.08 $3,105 - $4,651	-145 Reduced 1.24%	11,570 $272,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $17,342 - $21,285	-744 Reduced 5.97%	11,715 $327,000
Q3 2022 Oct 07, 2022	BUY	$23.4 - $34.25 $128,536 - $188,135	5,493 Added 78.85%	12,459 $292,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $1.88 Million - $2.3 Million	-59,225 Reduced 89.48%	6,966 $235,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $645,540 - $834,432	-21,200 Reduced 24.26%	66,191 $2.31 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $12.8 Million - $16.6 Million	-447,520 Reduced 83.66%	87,391 $2.66 Million
Q3 2021 Nov 08, 2021	BUY	$28.63 - $35.64 $15.3 Million - $19.1 Million	534,911 New	534,911 $17.5 Million

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.